Q&A coverage around endometriosis testing and women’s health diagnostics highlighted a growing push toward earlier diagnosis using noninvasive menstrual-blood multiomics. Multiple women-led companies are building multi-analyte approaches—often RNA-seq focused—that aim to reduce the current diagnostic delay driven by surgical confirmation and high rates of negative histology.